Drug Shortage Compounding Patient Access Act of 2025

Hozzl · 2025-09-24T15:04:00Z

Explore the details of House Bill 5316 Drug Shortage Compounding Patient Access Act of 2025 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

9/24/2025, 3:04 PM

Summary of Bill HR 5316

The bill titled "To amend the Federal Food, Drug, and Cosmetic Act to ensure patients have access to certain shortage and urgent-use compounded medications, and for other purposes" was introduced in the 119th Congress on September 11, 2025, as H.R. 5316.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 5316

Bill HR 5316 is currently in the status of Bill Introduced since September 11, 2025. Bill HR 5316 was introduced during Congress 119 and was introduced to the House on September 11, 2025. Bill HR 5316's most recent activity was Referred to the House Committee on Energy and Commerce. as of September 11, 2025

Bipartisan Support of Bill HR 5316

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 5316

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 5316

To amend the Federal Food, Drug, and Cosmetic Act to ensure patients have access to certain shortage and urgent-use compounded medications, and for other purposes.